| __timestamp | Sanofi | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 8565000000 | 612613000000 |
| Thursday, January 1, 2015 | 9496000000 | 650773000000 |
| Friday, January 1, 2016 | 9592000000 | 619061000000 |
| Sunday, January 1, 2017 | 10164000000 | 628106000000 |
| Monday, January 1, 2018 | 9934000000 | 717599000000 |
| Tuesday, January 1, 2019 | 9883000000 | 964737000000 |
| Wednesday, January 1, 2020 | 9390000000 | 875663000000 |
| Friday, January 1, 2021 | 9555000000 | 886361000000 |
| Saturday, January 1, 2022 | 10539000000 | 997309000000 |
| Sunday, January 1, 2023 | 10765000000 | 1053819000000 |
| Monday, January 1, 2024 | 9183000000 | 1053819000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Sanofi and Takeda Pharmaceutical Company Limited, two industry titans, have shown contrasting strategies over the past decade. From 2014 to 2023, Sanofi's SG&A expenses have remained relatively stable, fluctuating around 9.8 billion annually. In contrast, Takeda's expenses have soared, reaching over 1 trillion in 2023, a staggering increase of nearly 72% from 2014.
Sanofi's consistent approach suggests a focus on efficiency, while Takeda's rising costs may reflect aggressive expansion or increased operational complexity. The absence of data for Sanofi in 2024 leaves room for speculation on future strategies. As these companies navigate the ever-evolving pharmaceutical landscape, their SG&A management will be pivotal in maintaining competitive advantage.
Comparing SG&A Expenses: Merck & Co., Inc. vs Takeda Pharmaceutical Company Limited Trends and Insights
Novartis AG and Sanofi: SG&A Spending Patterns Compared
Sanofi or Alnylam Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Sanofi or Teva Pharmaceutical Industries Limited
Sanofi or Jazz Pharmaceuticals plc: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Sanofi and Mesoblast Limited
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Takeda Pharmaceutical Company Limited
Breaking Down SG&A Expenses: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Takeda Pharmaceutical Company Limited or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Merus N.V.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Geron Corporation